Mckesson Medical-Surgical Inc. Corporate Office: Drug Recall

Recall #D-0540-2025 · 04/21/2025

Class II: Risk

Recall Details

Recall Number
D-0540-2025
Classification
Class II
Product Type
Drug
Recalling Firm
Mckesson Medical-Surgical Inc. Corporate Office
Status
Ongoing
Date Initiated
04/21/2025
Location
Richmond, VA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3 Vials

Reason for Recall

CGMP Deviations; potential temperature excursions due to transit delays

Product Description

BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.

Distribution Pattern

Within the U.S - OH, VA, FL.

Other Recalls by Mckesson Medical-Surgical Inc. Corporate Office

View all recalls by Mckesson Medical-Surgical Inc. Corporate Office →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.